BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 18182992)

  • 21. Effect of ghrelin and anamorelin (ONO-7643), a selective ghrelin receptor agonist, on tumor growth in a lung cancer mouse xenograft model.
    Northrup R; Kuroda K; Duus EM; Barnes SR; Cheatham L; Wiley T; Pietra C
    Support Care Cancer; 2013 Sep; 21(9):2409-15. PubMed ID: 23579947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
    Zhang H; Garcia JM
    Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
    Naito T; Uchino J; Kojima T; Matano Y; Minato K; Tanaka K; Mizukami T; Atagi S; Higashiguchi T; Muro K; Takayama K; Furuse J; Morishima E; Takiguchi T; Tamura K
    Cancer; 2022 May; 128(10):2025-2035. PubMed ID: 35195274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sipjeondaebo-tang in patients with cancer with anorexia: a protocol for a pilot, randomised, controlled trial.
    Cheon C; Park S; Park YL; Huang CW; Ko Y; Jang BH; Shin YC; Ko SG
    BMJ Open; 2016 May; 6(5):e011212. PubMed ID: 27173813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging role of anamorelin hydrochloride in the management of patients with cancer anorexia-cachexia.
    Currow DC; Skipworth RJ
    Future Oncol; 2017 Aug; 13(20):1767-1783. PubMed ID: 28621564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer.
    Gebbia V; Testa A; Gebbia N
    Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.
    Wang W; Andersson M; Iresjö BM; Lönnroth C; Lundholm K
    Int J Oncol; 2006 Jun; 28(6):1393-400. PubMed ID: 16685441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects.
    Akamizu T; Takaya K; Irako T; Hosoda H; Teramukai S; Matsuyama A; Tada H; Miura K; Shimizu A; Fukushima M; Yokode M; Tanaka K; Kangawa K
    Eur J Endocrinol; 2004 Apr; 150(4):447-55. PubMed ID: 15080773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice.
    Perboni S; Bowers C; Kojima S; Asakawa A; Inui A
    World J Gastroenterol; 2008 Nov; 14(41):6303-5. PubMed ID: 19009643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potentiation of ghrelin signaling attenuates cancer anorexia-cachexia and prolongs survival.
    Fujitsuka N; Asakawa A; Uezono Y; Minami K; Yamaguchi T; Niijima A; Yada T; Maejima Y; Sedbazar U; Sakai T; Hattori T; Kase Y; Inui A
    Transl Psychiatry; 2011 Jul; 1(7):e23. PubMed ID: 22832525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapy.
    Graf SA; Garcia JM
    Drug Des Devel Ther; 2017; 11():2325-2331. PubMed ID: 28848326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite.
    Akamizu T; Iwakura H; Ariyasu H; Hosoda H; Murayama T; Yokode M; Teramukai S; Seno H; Chiba T; Noma S; Nakai Y; Fukunaga M; Nakai Y; Kangawa K;
    Eur J Endocrinol; 2008 Apr; 158(4):491-8. PubMed ID: 18362296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia.
    Loprinzi CL; Michalak JC; Schaid DJ; Mailliard JA; Athmann LM; Goldberg RM; Tschetter LK; Hatfield AK; Morton RF
    J Clin Oncol; 1993 Apr; 11(4):762-7. PubMed ID: 8478668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group.
    Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA
    Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on body weight and safety of RC-1291, a novel, orally available ghrelin mimetic and growth hormone secretagogue: results of a phase I, randomized, placebo-controlled, multiple-dose study in healthy volunteers.
    Garcia JM; Polvino WJ
    Oncologist; 2007 May; 12(5):594-600. PubMed ID: 17522248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women.
    Villa P; Costantini B; Perri C; Suriano R; Ricciardi L; Lanzone A
    Fertil Steril; 2008 Feb; 89(2):398-403. PubMed ID: 17509580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Solid Cancer Patients.
    Chaiworramukkul A; Seetalarom K; Saichamchan S; Prasongsook N
    Asian Pac J Cancer Prev; 2022 Jul; 23(7):2333-2340. PubMed ID: 35901339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial.
    Neary NM; Small CJ; Wren AM; Lee JL; Druce MR; Palmieri C; Frost GS; Ghatei MA; Coombes RC; Bloom SR
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2832-6. PubMed ID: 15181065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
    Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D
    Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.